INVITED AND SPECIAL SESSIONS
Wednesday, October 26
8:00 AM-9:30 AM
Concurrent Education Sessions I (2-4)
SESSION 4 - Chemical Genomics: Using Small Molecules and Genomics to Understand Biology and Disease
Hall 3
Moderator: Robert L. Nussbaum, National Human Genome Research Institute, Bethesda, MD
This session will introduce the audience to the current uses of chemical genomics, defined as the use of small molecules as probes of gene function, pathways, and cellular phenotypes relevant to health and disease. Chemical genomics is not just the purview of the drug discovery and development efforts of pharmaceutical and biotech companies--it is an active area of research and technology development that is being used to find powerful tools for investigating gene action and cellular physiology, both in normal and disease states. The session will also emphasize public databases of small molecule screen results as a new and important source of information previously unavailable outside of individual pharmaceutical companies.
8:00 AM Chemical genomics in the NIH Roadmap: Using small molecules and genomics to understand biology and disease. Christopher P. Austin, National Human Genome Research Institute, Bethesda, MD.
8:30 AM Chemical genomics to understand gene function. Randall W. King, Harvard Medical School, Boston, MA.
9:00 AM Chemical genomics in genetic disease. Kenneth H. Fischbeck, National Institute of Neurological Disorders and Stroke, Bethesda, MD.
